nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—ABCC1—Zoledronate—osteoporosis	0.252	0.643	CbGbCtD
Epirubicin—ABCC1—Conjugated Estrogens—osteoporosis	0.14	0.357	CbGbCtD
Epirubicin—AURKA—Calcipotriol—Calcitriol—osteoporosis	0.00143	0.181	CbGdCrCtD
Epirubicin—AURKA—Calcipotriol—Ergocalciferol—osteoporosis	0.00143	0.181	CbGdCrCtD
Epirubicin—AURKA—Calcipotriol—Cholecalciferol—osteoporosis	0.00121	0.154	CbGdCrCtD
Epirubicin—CHD1—uterus—osteoporosis	0.0011	0.153	CbGeAlD
Epirubicin—AURKA—Fulvestrant—Estradiol—osteoporosis	0.000942	0.12	CbGdCrCtD
Epirubicin—CHD1—bone marrow—osteoporosis	0.000936	0.13	CbGeAlD
Epirubicin—AURKA—uterus—osteoporosis	0.000889	0.124	CbGeAlD
Epirubicin—AURKA—bone marrow—osteoporosis	0.000754	0.105	CbGeAlD
Epirubicin—PLA2G4A—Estradiol—Estropipate—osteoporosis	0.000748	0.095	CbGdCrCtD
Epirubicin—YWHAG—uterus—osteoporosis	0.000682	0.0949	CbGeAlD
Epirubicin—DHCR7—bone marrow—osteoporosis	0.000631	0.0878	CbGeAlD
Epirubicin—YWHAG—bone marrow—osteoporosis	0.000579	0.0805	CbGeAlD
Epirubicin—PLA2G4A—Estradiol—Conjugated Estrogens—osteoporosis	0.000567	0.072	CbGdCrCtD
Epirubicin—TOP2A—uterus—osteoporosis	0.000484	0.0672	CbGeAlD
Epirubicin—PLA2G4A—Estradiol—Ethinyl Estradiol—osteoporosis	0.000476	0.0605	CbGdCrCtD
Epirubicin—PLA2G4A—bone marrow—osteoporosis	0.000432	0.0601	CbGeAlD
Epirubicin—TOP2A—bone marrow—osteoporosis	0.00041	0.0571	CbGeAlD
Epirubicin—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00036	0.0458	CbGdCrCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.00031	0.00196	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000304	0.00192	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000298	0.00188	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000295	0.00186	CbGpPWpGaD
Epirubicin—ABCC1—uterus—osteoporosis	0.000291	0.0405	CbGeAlD
Epirubicin—PLA2G4A—Opioid Signalling—POMC—osteoporosis	0.000285	0.0018	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—PSMA5—osteoporosis	0.000277	0.00175	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—PSMA2—osteoporosis	0.000277	0.00175	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—osteoporosis	0.000275	0.00173	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000272	0.00171	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000271	0.00171	CbGpPWpGaD
Epirubicin—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000269	0.0017	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—IDH2—osteoporosis	0.000266	0.00168	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—CYP19A1—osteoporosis	0.000265	0.00167	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000264	0.00167	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000263	0.00166	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—CYP19A1—osteoporosis	0.000261	0.00165	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—MGLL—osteoporosis	0.000261	0.00165	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.00025	0.00158	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP27A1—osteoporosis	0.00025	0.00158	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—AGER—osteoporosis	0.000247	0.00156	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000244	0.00154	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ACP5—osteoporosis	0.000243	0.00153	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.00024	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—PLEK—osteoporosis	0.000238	0.00151	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ANXA2—osteoporosis	0.000238	0.00151	CbGpPWpGaD
Epirubicin—TOP2A—Levorphanol—Estradiol—osteoporosis	0.000238	0.0302	CbGdCrCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000237	0.0015	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000235	0.00148	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000235	0.00148	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—TPI1—osteoporosis	0.000226	0.00143	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—osteoporosis	0.000226	0.00142	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MYC—osteoporosis	0.000218	0.00138	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.000217	0.0276	CbGdCrCtD
Epirubicin—DHCR7—Metabolism—P4HB—osteoporosis	0.000212	0.00134	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PSMA5—osteoporosis	0.00021	0.00133	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—PSMA2—osteoporosis	0.00021	0.00133	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GAPDH—osteoporosis	0.000208	0.00132	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—osteoporosis	0.000208	0.00131	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000207	0.0013	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TLN1—osteoporosis	0.000206	0.0013	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—RAP1A—osteoporosis	0.000203	0.00128	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VCL—osteoporosis	0.000203	0.00128	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000195	0.00123	CbGpPWpGaD
Epirubicin—YWHAG—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000192	0.00121	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.00019	0.0012	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00019	0.0012	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTH1R—osteoporosis	0.000188	0.00119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CALCR—osteoporosis	0.000188	0.00119	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—LEP—osteoporosis	0.000185	0.00117	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000184	0.00116	CbGpPWpGaD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.00018	0.00113	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000177	0.00112	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RAP1A—osteoporosis	0.000169	0.00107	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000165	0.00104	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000164	0.00104	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000164	0.00104	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ENO1—osteoporosis	0.000164	0.00104	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PSMA2—osteoporosis	0.000162	0.00102	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—PSMA5—osteoporosis	0.000162	0.00102	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000161	0.00102	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000159	0.00101	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000159	0.00101	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—POMC—osteoporosis	0.000159	0.001	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—FGA—osteoporosis	0.000154	0.00097	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000152	0.000957	CbGpPWpGaD
Epirubicin—YWHAG—Apoptosis—TNF—osteoporosis	0.000151	0.000951	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—FDPS—osteoporosis	0.00015	0.000947	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PKM—osteoporosis	0.00015	0.000947	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—osteoporosis	0.00015	0.000947	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—MGLL—osteoporosis	0.00015	0.000945	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PKM—osteoporosis	0.000147	0.000929	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—FDPS—osteoporosis	0.000147	0.000929	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PSMA2—osteoporosis	0.000147	0.000928	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—PSMA5—osteoporosis	0.000147	0.000928	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPD2—osteoporosis	0.000142	0.000898	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PGLS—osteoporosis	0.000142	0.000898	CbGpPWpGaD
Epirubicin—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000142	0.018	CbGdCrCtD
Epirubicin—ABCC1—Disease—PKM—osteoporosis	0.00014	0.000886	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SOST—osteoporosis	0.00014	0.000886	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—FGB—osteoporosis	0.00014	0.000883	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PGLS—osteoporosis	0.000139	0.000881	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPD2—osteoporosis	0.000139	0.000881	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000138	0.000871	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000136	0.000314	CcSEcCtD
Epirubicin—Fatigue—Ethinyl Estradiol—osteoporosis	0.000136	0.000313	CcSEcCtD
Epirubicin—Pruritus—Alendronate—osteoporosis	0.000136	0.000312	CcSEcCtD
Epirubicin—Dyspepsia—Risedronate—osteoporosis	0.000136	0.000312	CcSEcCtD
Epirubicin—Eye disorder—Estradiol—osteoporosis	0.000136	0.000312	CcSEcCtD
Epirubicin—Tinnitus—Estradiol—osteoporosis	0.000135	0.000311	CcSEcCtD
Epirubicin—Constipation—Ethinyl Estradiol—osteoporosis	0.000135	0.000311	CcSEcCtD
Epirubicin—Confusional state—Zoledronate—osteoporosis	0.000135	0.00031	CcSEcCtD
Epirubicin—Hypersensitivity—Calcitriol—osteoporosis	0.000135	0.00031	CcSEcCtD
Epirubicin—Cardiac disorder—Estradiol—osteoporosis	0.000135	0.00031	CcSEcCtD
Epirubicin—Flushing—Estradiol—osteoporosis	0.000135	0.00031	CcSEcCtD
Epirubicin—Chest pain—Conjugated Estrogens—osteoporosis	0.000134	0.000309	CcSEcCtD
Epirubicin—Arthralgia—Conjugated Estrogens—osteoporosis	0.000134	0.000309	CcSEcCtD
Epirubicin—Myalgia—Conjugated Estrogens—osteoporosis	0.000134	0.000309	CcSEcCtD
Epirubicin—Asthenia—Ibandronate—osteoporosis	0.000134	0.000308	CcSEcCtD
Epirubicin—Anxiety—Conjugated Estrogens—osteoporosis	0.000134	0.000308	CcSEcCtD
Epirubicin—Nausea—Etidronic acid—osteoporosis	0.000134	0.000308	CcSEcCtD
Epirubicin—Anaphylactic shock—Zoledronate—osteoporosis	0.000134	0.000308	CcSEcCtD
Epirubicin—Oedema—Zoledronate—osteoporosis	0.000134	0.000308	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000133	0.000307	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000133	0.000307	CcSEcCtD
Epirubicin—Diarrhoea—Estropipate—osteoporosis	0.000133	0.000307	CcSEcCtD
Epirubicin—ABCC1—Disease—ANTXR2—osteoporosis	0.000133	0.00084	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PGLS—osteoporosis	0.000133	0.00084	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Risedronate—osteoporosis	0.000133	0.000306	CcSEcCtD
Epirubicin—Infection—Zoledronate—osteoporosis	0.000133	0.000306	CcSEcCtD
Epirubicin—Fatigue—Risedronate—osteoporosis	0.000133	0.000305	CcSEcCtD
Epirubicin—Insomnia—Pamidronate—osteoporosis	0.000132	0.000305	CcSEcCtD
Epirubicin—Pruritus—Ibandronate—osteoporosis	0.000132	0.000304	CcSEcCtD
Epirubicin—Pain—Risedronate—osteoporosis	0.000132	0.000303	CcSEcCtD
Epirubicin—Constipation—Risedronate—osteoporosis	0.000132	0.000303	CcSEcCtD
Epirubicin—Angiopathy—Estradiol—osteoporosis	0.000132	0.000303	CcSEcCtD
Epirubicin—Shock—Zoledronate—osteoporosis	0.000132	0.000303	CcSEcCtD
Epirubicin—Paraesthesia—Pamidronate—osteoporosis	0.000131	0.000302	CcSEcCtD
Epirubicin—Diarrhoea—Alendronate—osteoporosis	0.000131	0.000302	CcSEcCtD
Epirubicin—Asthenia—Calcitriol—osteoporosis	0.000131	0.000302	CcSEcCtD
Epirubicin—Nervous system disorder—Zoledronate—osteoporosis	0.000131	0.000302	CcSEcCtD
Epirubicin—DHCR7—Metabolism—CYP19A1—osteoporosis	0.000131	0.000828	CbGpPWpGaD
Epirubicin—Immune system disorder—Estradiol—osteoporosis	0.000131	0.000301	CcSEcCtD
Epirubicin—Thrombocytopenia—Zoledronate—osteoporosis	0.000131	0.000301	CcSEcCtD
Epirubicin—Mediastinal disorder—Estradiol—osteoporosis	0.000131	0.000301	CcSEcCtD
Epirubicin—Dyspnoea—Pamidronate—osteoporosis	0.000131	0.0003	CcSEcCtD
Epirubicin—Tachycardia—Zoledronate—osteoporosis	0.000131	0.0003	CcSEcCtD
Epirubicin—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.00013	0.000299	CcSEcCtD
Epirubicin—Chills—Estradiol—osteoporosis	0.00013	0.000299	CcSEcCtD
Epirubicin—Somnolence—Pamidronate—osteoporosis	0.00013	0.000299	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—PNP—osteoporosis	0.00013	0.000821	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ATIC—osteoporosis	0.00013	0.000821	CbGpPWpGaD
Epirubicin—Skin disorder—Zoledronate—osteoporosis	0.00013	0.000299	CcSEcCtD
Epirubicin—Pruritus—Calcitriol—osteoporosis	0.000129	0.000298	CcSEcCtD
Epirubicin—Hyperhidrosis—Zoledronate—osteoporosis	0.000129	0.000297	CcSEcCtD
Epirubicin—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000129	0.000297	CcSEcCtD
Epirubicin—Diarrhoea—Raloxifene—osteoporosis	0.000129	0.000297	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000129	0.000814	CbGpPWpGaD
Epirubicin—Dyspepsia—Pamidronate—osteoporosis	0.000129	0.000296	CcSEcCtD
Epirubicin—Dizziness—Estropipate—osteoporosis	0.000129	0.000296	CcSEcCtD
Epirubicin—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000129	0.000296	CcSEcCtD
Epirubicin—Oedema—Conjugated Estrogens—osteoporosis	0.000129	0.000296	CcSEcCtD
Epirubicin—Alopecia—Estradiol—osteoporosis	0.000128	0.000295	CcSEcCtD
Epirubicin—Infection—Conjugated Estrogens—osteoporosis	0.000128	0.000294	CcSEcCtD
Epirubicin—Diarrhoea—Ibandronate—osteoporosis	0.000128	0.000294	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ATIC—osteoporosis	0.000128	0.000805	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PNP—osteoporosis	0.000128	0.000805	CbGpPWpGaD
Epirubicin—Anorexia—Zoledronate—osteoporosis	0.000127	0.000293	CcSEcCtD
Epirubicin—Decreased appetite—Pamidronate—osteoporosis	0.000127	0.000293	CcSEcCtD
Epirubicin—Mental disorder—Estradiol—osteoporosis	0.000127	0.000292	CcSEcCtD
Epirubicin—Dizziness—Alendronate—osteoporosis	0.000127	0.000292	CcSEcCtD
Epirubicin—Shock—Conjugated Estrogens—osteoporosis	0.000127	0.000291	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000126	0.000291	CcSEcCtD
Epirubicin—TOP2A—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000126	0.000798	CbGpPWpGaD
Epirubicin—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000126	0.00029	CcSEcCtD
Epirubicin—Malnutrition—Estradiol—osteoporosis	0.000126	0.00029	CcSEcCtD
Epirubicin—Erythema—Estradiol—osteoporosis	0.000126	0.00029	CcSEcCtD
Epirubicin—Fatigue—Pamidronate—osteoporosis	0.000126	0.00029	CcSEcCtD
Epirubicin—Gastrointestinal pain—Risedronate—osteoporosis	0.000126	0.00029	CcSEcCtD
Epirubicin—Tachycardia—Conjugated Estrogens—osteoporosis	0.000126	0.000289	CcSEcCtD
Epirubicin—Urticaria—Ethinyl Estradiol—osteoporosis	0.000125	0.000289	CcSEcCtD
Epirubicin—Constipation—Pamidronate—osteoporosis	0.000125	0.000288	CcSEcCtD
Epirubicin—Pain—Pamidronate—osteoporosis	0.000125	0.000288	CcSEcCtD
Epirubicin—Diarrhoea—Calcitriol—osteoporosis	0.000125	0.000288	CcSEcCtD
Epirubicin—Skin disorder—Conjugated Estrogens—osteoporosis	0.000125	0.000288	CcSEcCtD
Epirubicin—Hypotension—Zoledronate—osteoporosis	0.000125	0.000287	CcSEcCtD
Epirubicin—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000125	0.000287	CcSEcCtD
Epirubicin—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000125	0.000287	CcSEcCtD
Epirubicin—Dizziness—Raloxifene—osteoporosis	0.000125	0.000287	CcSEcCtD
Epirubicin—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000124	0.000286	CcSEcCtD
Epirubicin—Flatulence—Estradiol—osteoporosis	0.000124	0.000286	CcSEcCtD
Epirubicin—Tension—Estradiol—osteoporosis	0.000124	0.000285	CcSEcCtD
Epirubicin—Vomiting—Estropipate—osteoporosis	0.000124	0.000285	CcSEcCtD
Epirubicin—Dysgeusia—Estradiol—osteoporosis	0.000124	0.000284	CcSEcCtD
Epirubicin—Dizziness—Ibandronate—osteoporosis	0.000124	0.000284	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—SOST—osteoporosis	0.000123	0.000777	CbGpPWpGaD
Epirubicin—Rash—Estropipate—osteoporosis	0.000123	0.000283	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000123	0.000775	CbGpPWpGaD
Epirubicin—Dermatitis—Estropipate—osteoporosis	0.000123	0.000282	CcSEcCtD
Epirubicin—Anorexia—Conjugated Estrogens—osteoporosis	0.000123	0.000282	CcSEcCtD
Epirubicin—Nervousness—Estradiol—osteoporosis	0.000123	0.000282	CcSEcCtD
Epirubicin—Urticaria—Risedronate—osteoporosis	0.000122	0.000281	CcSEcCtD
Epirubicin—Back pain—Estradiol—osteoporosis	0.000122	0.000281	CcSEcCtD
Epirubicin—Headache—Estropipate—osteoporosis	0.000122	0.000281	CcSEcCtD
Epirubicin—Vomiting—Alendronate—osteoporosis	0.000122	0.000281	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000122	0.00028	CcSEcCtD
Epirubicin—Abdominal pain—Risedronate—osteoporosis	0.000122	0.00028	CcSEcCtD
Epirubicin—Body temperature increased—Risedronate—osteoporosis	0.000122	0.00028	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—osteoporosis	0.000122	0.000768	CbGpPWpGaD
Epirubicin—Muscle spasms—Estradiol—osteoporosis	0.000121	0.000279	CcSEcCtD
Epirubicin—Rash—Alendronate—osteoporosis	0.000121	0.000278	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—osteoporosis	0.000121	0.000764	CbGpPWpGaD
Epirubicin—Insomnia—Zoledronate—osteoporosis	0.000121	0.000278	CcSEcCtD
Epirubicin—Dermatitis—Alendronate—osteoporosis	0.000121	0.000278	CcSEcCtD
Epirubicin—Feeling abnormal—Pamidronate—osteoporosis	0.000121	0.000278	CcSEcCtD
Epirubicin—Hypotension—Conjugated Estrogens—osteoporosis	0.00012	0.000277	CcSEcCtD
Epirubicin—Headache—Alendronate—osteoporosis	0.00012	0.000277	CcSEcCtD
Epirubicin—Paraesthesia—Zoledronate—osteoporosis	0.00012	0.000276	CcSEcCtD
Epirubicin—Vomiting—Raloxifene—osteoporosis	0.00012	0.000276	CcSEcCtD
Epirubicin—Gastrointestinal pain—Pamidronate—osteoporosis	0.00012	0.000275	CcSEcCtD
Epirubicin—Dyspnoea—Zoledronate—osteoporosis	0.000119	0.000274	CcSEcCtD
Epirubicin—Rash—Raloxifene—osteoporosis	0.000119	0.000274	CcSEcCtD
Epirubicin—Dermatitis—Raloxifene—osteoporosis	0.000119	0.000274	CcSEcCtD
Epirubicin—Somnolence—Zoledronate—osteoporosis	0.000119	0.000273	CcSEcCtD
Epirubicin—Vomiting—Ibandronate—osteoporosis	0.000119	0.000273	CcSEcCtD
Epirubicin—Headache—Raloxifene—osteoporosis	0.000118	0.000272	CcSEcCtD
Epirubicin—Rash—Ibandronate—osteoporosis	0.000118	0.000271	CcSEcCtD
Epirubicin—Dermatitis—Ibandronate—osteoporosis	0.000118	0.000271	CcSEcCtD
Epirubicin—Dyspepsia—Zoledronate—osteoporosis	0.000118	0.000271	CcSEcCtD
Epirubicin—ABCC1—Metabolism—FDPS—osteoporosis	0.000118	0.000742	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PKM—osteoporosis	0.000118	0.000742	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000117	0.00027	CcSEcCtD
Epirubicin—Ill-defined disorder—Estradiol—osteoporosis	0.000117	0.00027	CcSEcCtD
Epirubicin—Headache—Ibandronate—osteoporosis	0.000117	0.000269	CcSEcCtD
Epirubicin—Insomnia—Conjugated Estrogens—osteoporosis	0.000116	0.000268	CcSEcCtD
Epirubicin—PLA2G4A—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000116	0.000735	CbGpPWpGaD
Epirubicin—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000116	0.000268	CcSEcCtD
Epirubicin—Vomiting—Calcitriol—osteoporosis	0.000116	0.000268	CcSEcCtD
Epirubicin—Decreased appetite—Zoledronate—osteoporosis	0.000116	0.000267	CcSEcCtD
Epirubicin—Agitation—Estradiol—osteoporosis	0.000116	0.000267	CcSEcCtD
Epirubicin—Nausea—Estropipate—osteoporosis	0.000116	0.000266	CcSEcCtD
Epirubicin—Abdominal pain—Pamidronate—osteoporosis	0.000116	0.000266	CcSEcCtD
Epirubicin—Body temperature increased—Pamidronate—osteoporosis	0.000116	0.000266	CcSEcCtD
Epirubicin—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000116	0.000266	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000115	0.000266	CcSEcCtD
Epirubicin—Rash—Calcitriol—osteoporosis	0.000115	0.000265	CcSEcCtD
Epirubicin—Fatigue—Zoledronate—osteoporosis	0.000115	0.000265	CcSEcCtD
Epirubicin—Dermatitis—Calcitriol—osteoporosis	0.000115	0.000265	CcSEcCtD
Epirubicin—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000115	0.000264	CcSEcCtD
Epirubicin—Headache—Calcitriol—osteoporosis	0.000115	0.000264	CcSEcCtD
Epirubicin—Somnolence—Conjugated Estrogens—osteoporosis	0.000114	0.000263	CcSEcCtD
Epirubicin—Pain—Zoledronate—osteoporosis	0.000114	0.000263	CcSEcCtD
Epirubicin—Constipation—Zoledronate—osteoporosis	0.000114	0.000263	CcSEcCtD
Epirubicin—Nausea—Alendronate—osteoporosis	0.000114	0.000262	CcSEcCtD
Epirubicin—Malaise—Estradiol—osteoporosis	0.000114	0.000262	CcSEcCtD
Epirubicin—Hypersensitivity—Risedronate—osteoporosis	0.000113	0.000261	CcSEcCtD
Epirubicin—Vertigo—Estradiol—osteoporosis	0.000113	0.000261	CcSEcCtD
Epirubicin—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000113	0.000261	CcSEcCtD
Epirubicin—Asthenia—Ethinyl Estradiol—osteoporosis	0.000113	0.000261	CcSEcCtD
Epirubicin—Syncope—Estradiol—osteoporosis	0.000113	0.00026	CcSEcCtD
Epirubicin—ABCC1—Disease—GSN—osteoporosis	0.000113	0.000714	CbGpPWpGaD
Epirubicin—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000113	0.0143	CbGdCrCtD
Epirubicin—Nausea—Raloxifene—osteoporosis	0.000112	0.000258	CcSEcCtD
Epirubicin—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000112	0.000257	CcSEcCtD
Epirubicin—Pruritus—Ethinyl Estradiol—osteoporosis	0.000112	0.000257	CcSEcCtD
Epirubicin—Palpitations—Estradiol—osteoporosis	0.000112	0.000257	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GPD2—osteoporosis	0.000111	0.000704	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PGLS—osteoporosis	0.000111	0.000704	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALCR—osteoporosis	0.000111	0.000703	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTH1R—osteoporosis	0.000111	0.000703	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000111	0.000256	CcSEcCtD
Epirubicin—Fatigue—Conjugated Estrogens—osteoporosis	0.000111	0.000255	CcSEcCtD
Epirubicin—Nausea—Ibandronate—osteoporosis	0.000111	0.000255	CcSEcCtD
Epirubicin—Loss of consciousness—Estradiol—osteoporosis	0.000111	0.000255	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—OXCT1—osteoporosis	0.000111	0.000698	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CA2—osteoporosis	0.000111	0.000698	CbGpPWpGaD
Epirubicin—Asthenia—Risedronate—osteoporosis	0.000111	0.000254	CcSEcCtD
Epirubicin—Feeling abnormal—Zoledronate—osteoporosis	0.00011	0.000254	CcSEcCtD
Epirubicin—Cough—Estradiol—osteoporosis	0.00011	0.000253	CcSEcCtD
Epirubicin—Constipation—Conjugated Estrogens—osteoporosis	0.00011	0.000253	CcSEcCtD
Epirubicin—Pain—Conjugated Estrogens—osteoporosis	0.00011	0.000253	CcSEcCtD
Epirubicin—Gastrointestinal pain—Zoledronate—osteoporosis	0.000109	0.000252	CcSEcCtD
Epirubicin—Hypertension—Estradiol—osteoporosis	0.000109	0.000251	CcSEcCtD
Epirubicin—Pruritus—Risedronate—osteoporosis	0.000109	0.000251	CcSEcCtD
Epirubicin—Nausea—Calcitriol—osteoporosis	0.000109	0.00025	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—OXCT1—osteoporosis	0.000108	0.000685	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CA2—osteoporosis	0.000108	0.000685	CbGpPWpGaD
Epirubicin—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000108	0.000249	CcSEcCtD
Epirubicin—Hypersensitivity—Pamidronate—osteoporosis	0.000108	0.000248	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—MGLL—osteoporosis	0.000108	0.000681	CbGpPWpGaD
Epirubicin—Arthralgia—Estradiol—osteoporosis	0.000108	0.000247	CcSEcCtD
Epirubicin—Myalgia—Estradiol—osteoporosis	0.000108	0.000247	CcSEcCtD
Epirubicin—Chest pain—Estradiol—osteoporosis	0.000108	0.000247	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ADCY5—osteoporosis	0.000107	0.000677	CbGpPWpGaD
Epirubicin—Anxiety—Estradiol—osteoporosis	0.000107	0.000246	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GPX1—osteoporosis	0.000107	0.000674	CbGpPWpGaD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000107	0.000246	CcSEcCtD
Epirubicin—Urticaria—Zoledronate—osteoporosis	0.000106	0.000244	CcSEcCtD
Epirubicin—Discomfort—Estradiol—osteoporosis	0.000106	0.000244	CcSEcCtD
Epirubicin—Abdominal pain—Zoledronate—osteoporosis	0.000106	0.000243	CcSEcCtD
Epirubicin—Body temperature increased—Zoledronate—osteoporosis	0.000106	0.000243	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—MGLL—osteoporosis	0.000106	0.000667	CbGpPWpGaD
Epirubicin—Diarrhoea—Risedronate—osteoporosis	0.000105	0.000242	CcSEcCtD
Epirubicin—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000105	0.000242	CcSEcCtD
Epirubicin—Dry mouth—Estradiol—osteoporosis	0.000105	0.000242	CcSEcCtD
Epirubicin—Asthenia—Pamidronate—osteoporosis	0.000105	0.000242	CcSEcCtD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—osteoporosis	0.000105	0.00066	CbGpPWpGaD
Epirubicin—Dizziness—Ethinyl Estradiol—osteoporosis	0.000104	0.00024	CcSEcCtD
Epirubicin—Confusional state—Estradiol—osteoporosis	0.000104	0.000239	CcSEcCtD
Epirubicin—Pruritus—Pamidronate—osteoporosis	0.000104	0.000238	CcSEcCtD
Epirubicin—Anaphylactic shock—Estradiol—osteoporosis	0.000103	0.000237	CcSEcCtD
Epirubicin—Oedema—Estradiol—osteoporosis	0.000103	0.000237	CcSEcCtD
Epirubicin—Infection—Estradiol—osteoporosis	0.000102	0.000236	CcSEcCtD
Epirubicin—Urticaria—Conjugated Estrogens—osteoporosis	0.000102	0.000235	CcSEcCtD
Epirubicin—ABCC1—Metabolism—PNP—osteoporosis	0.000102	0.000644	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ATIC—osteoporosis	0.000102	0.000644	CbGpPWpGaD
Epirubicin—Dizziness—Risedronate—osteoporosis	0.000102	0.000234	CcSEcCtD
Epirubicin—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000102	0.000234	CcSEcCtD
Epirubicin—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000102	0.000234	CcSEcCtD
Epirubicin—Shock—Estradiol—osteoporosis	0.000101	0.000233	CcSEcCtD
Epirubicin—Nervous system disorder—Estradiol—osteoporosis	0.000101	0.000232	CcSEcCtD
Epirubicin—Tachycardia—Estradiol—osteoporosis	0.000101	0.000231	CcSEcCtD
Epirubicin—Vomiting—Ethinyl Estradiol—osteoporosis	0.0001	0.000231	CcSEcCtD
Epirubicin—Diarrhoea—Pamidronate—osteoporosis	0.0001	0.00023	CcSEcCtD
Epirubicin—Skin disorder—Estradiol—osteoporosis	0.0001	0.00023	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.97e-05	0.000629	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Estradiol—osteoporosis	9.96e-05	0.000229	CcSEcCtD
Epirubicin—Rash—Ethinyl Estradiol—osteoporosis	9.96e-05	0.000229	CcSEcCtD
Epirubicin—Dermatitis—Ethinyl Estradiol—osteoporosis	9.95e-05	0.000229	CcSEcCtD
Epirubicin—Headache—Ethinyl Estradiol—osteoporosis	9.9e-05	0.000228	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—PTH—osteoporosis	9.9e-05	0.000625	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—MTHFR—osteoporosis	9.86e-05	0.000622	CbGpPWpGaD
Epirubicin—Hypersensitivity—Zoledronate—osteoporosis	9.85e-05	0.000227	CcSEcCtD
Epirubicin—ABCC1—Disease—LRP5—osteoporosis	9.84e-05	0.000622	CbGpPWpGaD
Epirubicin—Vomiting—Risedronate—osteoporosis	9.79e-05	0.000225	CcSEcCtD
Epirubicin—Rash—Risedronate—osteoporosis	9.71e-05	0.000223	CcSEcCtD
Epirubicin—Dermatitis—Risedronate—osteoporosis	9.7e-05	0.000223	CcSEcCtD
Epirubicin—Dizziness—Pamidronate—osteoporosis	9.68e-05	0.000223	CcSEcCtD
Epirubicin—Headache—Risedronate—osteoporosis	9.65e-05	0.000222	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CNR2—osteoporosis	9.64e-05	0.000609	CbGpPWpGaD
Epirubicin—Asthenia—Zoledronate—osteoporosis	9.6e-05	0.000221	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	9.57e-05	0.000604	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	9.55e-05	0.000603	CbGpPWpGaD
Epirubicin—Hypersensitivity—Conjugated Estrogens—osteoporosis	9.49e-05	0.000218	CcSEcCtD
Epirubicin—Pruritus—Zoledronate—osteoporosis	9.46e-05	0.000218	CcSEcCtD
Epirubicin—ABCC1—Disease—LRP6—osteoporosis	9.42e-05	0.000594	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Estradiol—osteoporosis	9.39e-05	0.000216	CcSEcCtD
Epirubicin—Nausea—Ethinyl Estradiol—osteoporosis	9.38e-05	0.000216	CcSEcCtD
Epirubicin—Insomnia—Estradiol—osteoporosis	9.32e-05	0.000214	CcSEcCtD
Epirubicin—Vomiting—Pamidronate—osteoporosis	9.31e-05	0.000214	CcSEcCtD
Epirubicin—Paraesthesia—Estradiol—osteoporosis	9.25e-05	0.000213	CcSEcCtD
Epirubicin—Asthenia—Conjugated Estrogens—osteoporosis	9.24e-05	0.000213	CcSEcCtD
Epirubicin—Rash—Pamidronate—osteoporosis	9.23e-05	0.000212	CcSEcCtD
Epirubicin—Dermatitis—Pamidronate—osteoporosis	9.22e-05	0.000212	CcSEcCtD
Epirubicin—Dyspnoea—Estradiol—osteoporosis	9.19e-05	0.000211	CcSEcCtD
Epirubicin—Headache—Pamidronate—osteoporosis	9.17e-05	0.000211	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—IDH2—osteoporosis	9.17e-05	0.000579	CbGpPWpGaD
Epirubicin—Somnolence—Estradiol—osteoporosis	9.16e-05	0.000211	CcSEcCtD
Epirubicin—Diarrhoea—Zoledronate—osteoporosis	9.15e-05	0.00021	CcSEcCtD
Epirubicin—Nausea—Risedronate—osteoporosis	9.15e-05	0.00021	CcSEcCtD
Epirubicin—Pruritus—Conjugated Estrogens—osteoporosis	9.11e-05	0.00021	CcSEcCtD
Epirubicin—Dyspepsia—Estradiol—osteoporosis	9.07e-05	0.000209	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—WNT1—osteoporosis	9.07e-05	0.000572	CbGpPWpGaD
Epirubicin—ABCC1—Disease—LTF—osteoporosis	9.05e-05	0.000571	CbGpPWpGaD
Epirubicin—ABCC1—Disease—RPL24—osteoporosis	9.05e-05	0.000571	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—IDH2—osteoporosis	8.99e-05	0.000568	CbGpPWpGaD
Epirubicin—Decreased appetite—Estradiol—osteoporosis	8.96e-05	0.000206	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.92e-05	0.000563	CbGpPWpGaD
Epirubicin—Gastrointestinal disorder—Estradiol—osteoporosis	8.9e-05	0.000205	CcSEcCtD
Epirubicin—Fatigue—Estradiol—osteoporosis	8.89e-05	0.000204	CcSEcCtD
Epirubicin—Dizziness—Zoledronate—osteoporosis	8.84e-05	0.000203	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—MGLL—osteoporosis	8.84e-05	0.000558	CbGpPWpGaD
Epirubicin—Constipation—Estradiol—osteoporosis	8.81e-05	0.000203	CcSEcCtD
Epirubicin—Pain—Estradiol—osteoporosis	8.81e-05	0.000203	CcSEcCtD
Epirubicin—Diarrhoea—Conjugated Estrogens—osteoporosis	8.81e-05	0.000203	CcSEcCtD
Epirubicin—AURKA—Cell Cycle, Mitotic—MYC—osteoporosis	8.74e-05	0.000552	CbGpPWpGaD
Epirubicin—Nausea—Pamidronate—osteoporosis	8.7e-05	0.0002	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CA2—osteoporosis	8.67e-05	0.000547	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—OXCT1—osteoporosis	8.67e-05	0.000547	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LRP5—osteoporosis	8.63e-05	0.000545	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP27A1—osteoporosis	8.62e-05	0.000544	CbGpPWpGaD
Epirubicin—Dizziness—Conjugated Estrogens—osteoporosis	8.52e-05	0.000196	CcSEcCtD
Epirubicin—Vomiting—Zoledronate—osteoporosis	8.5e-05	0.000196	CcSEcCtD
Epirubicin—Feeling abnormal—Estradiol—osteoporosis	8.49e-05	0.000195	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—CYP27A1—osteoporosis	8.45e-05	0.000534	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MGLL—osteoporosis	8.45e-05	0.000533	CbGpPWpGaD
Epirubicin—Rash—Zoledronate—osteoporosis	8.43e-05	0.000194	CcSEcCtD
Epirubicin—Gastrointestinal pain—Estradiol—osteoporosis	8.43e-05	0.000194	CcSEcCtD
Epirubicin—Dermatitis—Zoledronate—osteoporosis	8.42e-05	0.000194	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ACP5—osteoporosis	8.38e-05	0.000529	CbGpPWpGaD
Epirubicin—Headache—Zoledronate—osteoporosis	8.38e-05	0.000193	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.29e-05	0.000524	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.27e-05	0.000522	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LRP6—osteoporosis	8.25e-05	0.000521	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ACP5—osteoporosis	8.22e-05	0.000519	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PTHLH—osteoporosis	8.2e-05	0.000518	CbGpPWpGaD
Epirubicin—Vomiting—Conjugated Estrogens—osteoporosis	8.19e-05	0.000188	CcSEcCtD
Epirubicin—Urticaria—Estradiol—osteoporosis	8.19e-05	0.000188	CcSEcCtD
Epirubicin—Body temperature increased—Estradiol—osteoporosis	8.15e-05	0.000187	CcSEcCtD
Epirubicin—Abdominal pain—Estradiol—osteoporosis	8.15e-05	0.000187	CcSEcCtD
Epirubicin—Rash—Conjugated Estrogens—osteoporosis	8.12e-05	0.000187	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.12e-05	0.000512	CbGpPWpGaD
Epirubicin—Dermatitis—Conjugated Estrogens—osteoporosis	8.11e-05	0.000187	CcSEcCtD
Epirubicin—Headache—Conjugated Estrogens—osteoporosis	8.07e-05	0.000186	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.97e-05	0.000503	CbGpPWpGaD
Epirubicin—Nausea—Zoledronate—osteoporosis	7.94e-05	0.000183	CcSEcCtD
Epirubicin—DHCR7—Metabolism—POMC—osteoporosis	7.88e-05	0.000498	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ACP5—osteoporosis	7.84e-05	0.000495	CbGpPWpGaD
Epirubicin—AURKA—Cell Cycle—MYC—osteoporosis	7.82e-05	0.000494	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—TPI1—osteoporosis	7.79e-05	0.000492	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	7.73e-05	0.000488	CbGpPWpGaD
Epirubicin—Nausea—Conjugated Estrogens—osteoporosis	7.65e-05	0.000176	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—TPI1—osteoporosis	7.64e-05	0.000483	CbGpPWpGaD
Epirubicin—Hypersensitivity—Estradiol—osteoporosis	7.59e-05	0.000175	CcSEcCtD
Epirubicin—Asthenia—Estradiol—osteoporosis	7.39e-05	0.00017	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	7.36e-05	0.000465	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—P4HB—osteoporosis	7.33e-05	0.000463	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TPI1—osteoporosis	7.29e-05	0.00046	CbGpPWpGaD
Epirubicin—Pruritus—Estradiol—osteoporosis	7.29e-05	0.000168	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CALCA—osteoporosis	7.22e-05	0.000456	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GAPDH—osteoporosis	7.19e-05	0.000454	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—P4HB—osteoporosis	7.19e-05	0.000454	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—IDH2—osteoporosis	7.18e-05	0.000453	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GAPDH—osteoporosis	7.05e-05	0.000445	CbGpPWpGaD
Epirubicin—Diarrhoea—Estradiol—osteoporosis	7.05e-05	0.000162	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—RAP1A—osteoporosis	7.01e-05	0.000442	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TLN1—osteoporosis	6.97e-05	0.00044	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—osteoporosis	6.91e-05	0.000436	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RAP1A—osteoporosis	6.87e-05	0.000434	CbGpPWpGaD
Epirubicin—ABCC1—Disease—P4HB—osteoporosis	6.86e-05	0.000433	CbGpPWpGaD
Epirubicin—Dizziness—Estradiol—osteoporosis	6.82e-05	0.000157	CcSEcCtD
Epirubicin—ABCC1—Metabolism—CYP27A1—osteoporosis	6.75e-05	0.000426	CbGpPWpGaD
Epirubicin—ABCC1—Disease—GAPDH—osteoporosis	6.73e-05	0.000425	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle, Mitotic—MYC—osteoporosis	6.63e-05	0.000418	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ACP5—osteoporosis	6.57e-05	0.000415	CbGpPWpGaD
Epirubicin—Vomiting—Estradiol—osteoporosis	6.55e-05	0.000151	CcSEcCtD
Epirubicin—Rash—Estradiol—osteoporosis	6.5e-05	0.000149	CcSEcCtD
Epirubicin—Dermatitis—Estradiol—osteoporosis	6.49e-05	0.000149	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	6.49e-05	0.000409	CbGpPWpGaD
Epirubicin—Headache—Estradiol—osteoporosis	6.46e-05	0.000149	CcSEcCtD
Epirubicin—ABCC1—Disease—NFATC1—osteoporosis	6.39e-05	0.000404	CbGpPWpGaD
Epirubicin—ABCC1—Disease—DKK1—osteoporosis	6.34e-05	0.000401	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—IGF1—osteoporosis	6.33e-05	0.0004	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.19e-05	0.000391	CbGpPWpGaD
Epirubicin—Nausea—Estradiol—osteoporosis	6.12e-05	0.000141	CcSEcCtD
Epirubicin—ABCC1—Disease—WNT1—osteoporosis	6.11e-05	0.000386	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—TPI1—osteoporosis	6.11e-05	0.000386	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—P4HB—osteoporosis	6.01e-05	0.000379	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.99e-05	0.000378	CbGpPWpGaD
Epirubicin—ABCC1—Disease—FGA—osteoporosis	5.94e-05	0.000375	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—MYC—osteoporosis	5.93e-05	0.000374	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTH—osteoporosis	5.85e-05	0.000369	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAP1A—osteoporosis	5.74e-05	0.000363	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—P4HB—osteoporosis	5.74e-05	0.000362	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CNR2—osteoporosis	5.7e-05	0.00036	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ENO1—osteoporosis	5.66e-05	0.000358	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GAPDH—osteoporosis	5.64e-05	0.000356	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NFATC1—osteoporosis	5.6e-05	0.000354	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSMA5—osteoporosis	5.58e-05	0.000352	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—PSMA2—osteoporosis	5.58e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—DKK1—osteoporosis	5.56e-05	0.000351	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ENO1—osteoporosis	5.55e-05	0.000351	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—RAP1A—osteoporosis	5.49e-05	0.000347	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSMA2—osteoporosis	5.47e-05	0.000345	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—PSMA5—osteoporosis	5.47e-05	0.000345	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—WNT1—osteoporosis	5.36e-05	0.000338	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ENO1—osteoporosis	5.3e-05	0.000335	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMA5—osteoporosis	5.22e-05	0.00033	CbGpPWpGaD
Epirubicin—ABCC1—Disease—PSMA2—osteoporosis	5.22e-05	0.00033	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGA—osteoporosis	5.21e-05	0.000329	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—ADCY5—osteoporosis	5.13e-05	0.000324	CbGpPWpGaD
Epirubicin—ABCC1—Disease—CALCA—osteoporosis	4.87e-05	0.000307	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—BMP2—osteoporosis	4.84e-05	0.000306	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PTHLH—osteoporosis	4.84e-05	0.000306	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.79e-05	0.000302	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—FGB—osteoporosis	4.74e-05	0.000299	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	4.64e-05	0.000293	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMA2—osteoporosis	4.58e-05	0.000289	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—PSMA5—osteoporosis	4.58e-05	0.000289	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP19A1—osteoporosis	4.53e-05	0.000286	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP19A1—osteoporosis	4.44e-05	0.00028	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ENO1—osteoporosis	4.44e-05	0.00028	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KL—osteoporosis	4.42e-05	0.000279	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMA2—osteoporosis	4.37e-05	0.000276	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—PSMA5—osteoporosis	4.37e-05	0.000276	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CALCA—osteoporosis	4.26e-05	0.000269	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—MYC—osteoporosis	4.14e-05	0.000262	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KL—osteoporosis	3.87e-05	0.000244	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—osteoporosis	3.79e-05	0.00024	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—POMC—osteoporosis	3.78e-05	0.000238	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ADCY5—osteoporosis	3.7e-05	0.000234	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GPX1—osteoporosis	3.69e-05	0.000233	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6R—osteoporosis	3.68e-05	0.000233	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ADCY5—osteoporosis	3.63e-05	0.000229	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GPX1—osteoporosis	3.62e-05	0.000228	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP19A1—osteoporosis	3.55e-05	0.000224	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ADCY5—osteoporosis	3.46e-05	0.000218	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—MTHFR—osteoporosis	3.4e-05	0.000215	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—MTHFR—osteoporosis	3.34e-05	0.000211	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MTHFR—osteoporosis	3.18e-05	0.000201	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADCY5—osteoporosis	3.03e-05	0.000191	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS2—osteoporosis	3.03e-05	0.000191	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SPP1—osteoporosis	2.93e-05	0.000185	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ADCY5—osteoporosis	2.9e-05	0.000183	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GPX1—osteoporosis	2.89e-05	0.000182	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—POMC—osteoporosis	2.72e-05	0.000172	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—POMC—osteoporosis	2.67e-05	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—MTHFR—osteoporosis	2.67e-05	0.000168	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS2—osteoporosis	2.65e-05	0.000168	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IRS1—osteoporosis	2.64e-05	0.000167	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—osteoporosis	2.6e-05	0.000164	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6R—osteoporosis	2.48e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ESR1—osteoporosis	2.48e-05	0.000157	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IRS1—osteoporosis	2.32e-05	0.000146	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—POMC—osteoporosis	2.23e-05	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6R—osteoporosis	2.18e-05	0.000137	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IGF1—osteoporosis	2.15e-05	0.000135	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—POMC—osteoporosis	2.13e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—osteoporosis	1.64e-05	0.000104	CbGpPWpGaD
Epirubicin—ABCC1—Disease—MYC—osteoporosis	1.47e-05	9.29e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—osteoporosis	1.47e-05	9.27e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MYC—osteoporosis	1.29e-05	8.14e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—osteoporosis	1.29e-05	8.12e-05	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—osteoporosis	1.11e-05	6.98e-05	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—osteoporosis	9.69e-06	6.12e-05	CbGpPWpGaD
